Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Sell
46
QDEL Quote, Financials, Valuation and Earnings
Last price:
$46.70
Seasonality move
:
4.1%
Day range:
$44.68 - $45.91
52-week range:
$29.74 - $75.09
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.07x
P/B ratio:
0.95x
Volume:
594.2K
Avg. volume:
1.1M
1-year change:
-39.73%
Market cap:
$3B
Revenue:
$3B
EPS (TTM):
-$27.90
Analysts' Opinion
-
Consensus RatingQuidelOrtho has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $50.29, QuidelOrtho has an estimated upside of 13.55% from its current price of $45.04.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $38.00 representing 100% downside risk from its current price of $45.04.
Fair Value
-
According to the consensus of 5 analysts, QuidelOrtho has 13.55% upside to fair value with a price target of $50.29 per share.
QDEL vs. S&P 500
-
Over the past 5 trading days, QuidelOrtho has overperformed the S&P 500 by 2.79% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
QuidelOrtho does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
QuidelOrtho revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter QuidelOrtho reported revenues of $727.1M.
Earnings Growth
-
QuidelOrtho earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter QuidelOrtho reported earnings per share of -$0.30.
Enterprise value:
5.4B
EV / Invested capital:
--
Price / LTM sales:
1.07x
EV / EBIT:
--
EV / Revenue:
1.93x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-56.16x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.3B
Return On Assets:
-25.02%
Net Income Margin (TTM):
-66.25%
Return On Equity:
-47.52%
Return On Invested Capital:
-29.13%
Operating Margin:
7.12%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $3B | $3.1B | $2.8B | $744M | $727.1M | |
| Gross Profit | $2B | $1.6B | $1.3B | $369.4M | $352.3M | |
| Operating Income | $1.3B | $295M | $100.5M | $55M | $51.8M | |
| EBITDA | $1.3B | $649.5M | -$1.4B | $144.2M | $133.8M | |
| Diluted EPS | $18.80 | $0.19 | -$27.90 | -$0.19 | -$0.30 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $560.9M | $1.1B | $1.4B | $1.4B | $1.4B | |
| Total Assets | $1.2B | $2.1B | $8.7B | $8.5B | $6.8B | |
| Current Liabilities | $207.9M | $297.1M | $872.7M | $860M | $1B | |
| Total Liabilities | $400.1M | $472.3M | $3.9B | $3.6B | $3.6B | |
| Total Equity | $849.2M | $1.6B | $4.8B | $5B | $3.2B | |
| Total Debt | $6.7M | -- | $2.7B | $2.5B | $2.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1B | $369.2M | $99.7M | $41.5M | $117.9M | |
| Cash From Investing | -$1.7B | -$191.8M | -$167.1M | -$21.3M | -$56.5M | |
| Cash From Financing | $282.8M | -$239.7M | $59.9M | -$48.7M | -$26.3M | |
| Free Cash Flow | $925.7M | $146.8M | -$96.8M | -$1.9M | $71.4M | |
QDEL
Sector
Market Cap
$3B
$48.6M
Price % of 52-Week High
59.98%
47.39%
Dividend Yield
0%
0%
Shareholder Yield
-0.27%
-0.74%
1-Year Price Total Return
-39.73%
-33.25%
Beta (5-Year)
0.079
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$44.57
200-day SMA
Buy
Level
$41.09
Bollinger Bands (100)
Buy
Level
39.59 - 44.67
Chaikin Money Flow
Buy
Level
56.7M
20-day SMA
Buy
Level
$42.40
Relative Strength Index (RSI14)
Buy
Level
62.34
ADX Line
Buy
Level
17.13
Williams %R
Sell
Level
-17.6916
50-day SMA
Buy
Level
$40.69
MACD (12, 26)
Buy
Level
1.22
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
58.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6615)
Buy
CA Score
(Annual)
Level (0.0715)
Buy
Beneish M-Score
(Annual)
Level (-2.9265)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-29.7852)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Stock Forecast FAQ
In the current month, QDEL has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The QDEL average analyst price target in the past 3 months is $50.29.
-
Where Will QuidelOrtho Stock Be In 1 Year?
According to analysts, the consensus estimate is that QuidelOrtho share price will rise to $50.29 per share over the next 12 months.
-
What Do Analysts Say About QuidelOrtho?
Analysts are divided on their view about QuidelOrtho share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that QuidelOrtho is a Sell and believe this share price will drop from its current level to $38.00.
-
What Is QuidelOrtho's Price Target?
The price target for QuidelOrtho over the next 1-year time period is forecast to be $50.29 according to 5 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is QDEL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for QuidelOrtho is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of QDEL?
You can purchase shares of QuidelOrtho via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase QuidelOrtho shares.
-
What Is The QuidelOrtho Share Price Today?
QuidelOrtho was last trading at $46.70 per share. This represents the most recent stock quote for QuidelOrtho. Yesterday, QuidelOrtho closed at $45.04 per share.
-
How To Buy QuidelOrtho Stock Online?
In order to purchase QuidelOrtho stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 3
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
88
BMA alert for Jan 3
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
50
AGFY alert for Jan 3
Agrify [AGFY] is down 5.86% over the past day.
